Stock Snapshot from
Osiris Therapeutics IncAdd to My Watchlist
OSIR:USNASDAQ GMIndustry: Therapeutics
- 11.01Last
- 0.06 -0.54%Today's Change
- 11.07Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.380 |
| EPS: Year Est. 12/13 ttm | -0.305 |
| EPS: Quarterly Actual 3/13 | -0.08 |
| EPS: Quarterly Est. 6/13 | -0.09 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -- |
Company Description
| Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects. | |
| Revenue | $12 million |
| Net Income | $-11 million |
| Total Assets | $41 million |
| Employees | 59 |
| Web Site | www.Osiris.com |
Latest Headlines
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.